Statistical Considerations on the Evaluation of Imbalances of Adverse Events in Randomized Clinical Trials

This article highlights key aspects that need attention and statistical analysis approaches that could be helpful for screening and evaluation of signals generated from imbalances of AEs in moderate or large RCTs.

Source: Therapeutic Innovation and Regulatory Science - October 21, 2015 Category: Drugs & Pharmacology Authors: Ma, H., Ke, C., Jiang, Q., Snapinn, S. Tags: Biostatistics Source Type: research